Trials / Unknown
UnknownNCT01865097
Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease
Pilot Study of Relaxation Guided Imagery for Treatment of Pain in Parkinson's Disease
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 30 Years
- Healthy volunteers
- Not accepted
Summary
Parkinson's disease patients may have severe non-motor symptoms. A common and troublesome non-motor symptom is pain. Currently these symptoms are treated with medication with limited success. Our study aims to determine whether relaxation guided imagery can alleviate pain in Parkinson's disease patients.
Detailed description
Parkinson's disease patients with severe pain without dementia will participate in this study aimed to examine a possible beneficial effect of relaxation guided imagery on pain. This will be a phase I, controlled, single blind and randomized efficacy study in 2 parallel groups. The study will include a baseline assessment of pain severity where after the intervention group will undergo relaxation guided imagery and the control group will listen to relaxing music. After these relaxation session patients will receive a CD with either relaxation guided imagery or relaxing music to listen to at home. Pain severity will be recorded for the following 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Relaxation guided imagery | An individualized relaxation guided imagery session will be conducted. After the session patients will be given a CD with the relaxation guided imagery and asked to listen to it at home. |
| BEHAVIORAL | Relaxing music | An individualized session of listening to relaxing music will be conducted. After the session patients will be given a CD with the relaxing music and asked to listen to it at home. |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2015-12-01
- First posted
- 2013-05-30
- Last updated
- 2014-11-06
Source: ClinicalTrials.gov record NCT01865097. Inclusion in this directory is not an endorsement.